Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard W Franck

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Cancer Research|August 3, 2007
Combined natural killer T-cell based immunotherapy eradicates established tumors in miceMichele W L Teng, Jennifer A Westwood, Phillip K Darcy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2008
Activation of invariant NKT cells ameliorates experimental ocular autoimmunity by a mechanism involving innate IFN-gamma production and dampening of the adaptive Th1 and Th17 responsesRafael S Grajewski, Anna M Hansen, Rajeev K Agarwal, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2007
A single early activation of invariant NK T cells confers long-term protection against collagen-induced arthritis in a ligand-specific mannerKen Coppieters, Katrien Van Beneden, Peggy Jacques, et al.
The Journal of Biological Chemistry|May 29, 2015
Lipid and Carbohydrate Modifications of α-Galactosylceramide Differently Influence Mouse and Human Type I Natural Killer T Cell ActivationAlysia Birkholz, Marek Nemčovič, Esther Dawen Yu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2011
NKT TCR recognition of CD1d-α-C-galactosylceramideOnisha Patel, Garth Cameron, Daniel G Pellicci, et al.
The EMBO Journal|May 10, 2011
Galactose-modified iNKT cell agonists stabilized by an induced fit of CD1d prevent tumour metastasisSandrine Aspeslagh, Yali Li, Esther Dawen Yu, et al.
The Journal of Clinical Investigation|December 16, 2010
Influenza infection in suckling mice expands an NKT cell subset that protects against airway hyperreactivityYa-Jen Chang, Hye Young Kim, Lee A Albacker, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Cancer Research|August 3, 2007
Combined natural killer T-cell based immunotherapy eradicates established tumors in miceMichele W L Teng, Jennifer A Westwood, Phillip K Darcy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2008
Activation of invariant NKT cells ameliorates experimental ocular autoimmunity by a mechanism involving innate IFN-gamma production and dampening of the adaptive Th1 and Th17 responsesRafael S Grajewski, Anna M Hansen, Rajeev K Agarwal, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2007
A single early activation of invariant NK T cells confers long-term protection against collagen-induced arthritis in a ligand-specific mannerKen Coppieters, Katrien Van Beneden, Peggy Jacques, et al.
The Journal of Biological Chemistry|May 29, 2015
Lipid and Carbohydrate Modifications of α-Galactosylceramide Differently Influence Mouse and Human Type I Natural Killer T Cell ActivationAlysia Birkholz, Marek Nemčovič, Esther Dawen Yu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2011
NKT TCR recognition of CD1d-α-C-galactosylceramideOnisha Patel, Garth Cameron, Daniel G Pellicci, et al.
The EMBO Journal|May 10, 2011
Galactose-modified iNKT cell agonists stabilized by an induced fit of CD1d prevent tumour metastasisSandrine Aspeslagh, Yali Li, Esther Dawen Yu, et al.
The Journal of Clinical Investigation|December 16, 2010
Influenza infection in suckling mice expands an NKT cell subset that protects against airway hyperreactivityYa-Jen Chang, Hye Young Kim, Lee A Albacker, et al.
Pageof 3